| Lastest Insider Transactions Of Aktis Oncology, Inc. ( AKTS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AKTS | Aktis Oncology, Inc. | Foley Todd | Directior 10% Owner | 2026-01-12 | Buy | 232,870 | 18.00 | 4,191,660 | 2026-01-14 18:20:21 |
| AKTS | Aktis Oncology, Inc. | MPM BIOVENTURES 2018, L.P. | 10% Owner | 2026-01-12 | Buy | 1,112,777 | 18.00 | 20,029,986 | 2026-01-14 18:19:26 |
| AKTS | Aktis Oncology, Inc. | GADICKE ANSBERT | 10% Owner | 2026-01-12 | Buy | 1,112,777 | 18.00 | 20,029,986 | 2026-01-14 18:17:54 |
| AKTS | Aktis Oncology, Inc. | EcoR1 Capital, LLC | Directior | 2026-01-12 | Buy | 2,222,222 | 18.00 | 39,999,996 | 2026-01-12 20:28:36 |
| AKTS | Aktis Oncology, Inc. | Vida Ventures II, LLC | 10% Owner | 2026-01-12 | Buy | 835,000 | 18.00 | 15,030,000 | 2026-01-12 17:10:07 |
| AKTS | Aktis Oncology, Inc. | Kim Helen Susan | Directior 10% Owner | 2026-01-12 | Buy | 835,000 | 18.00 | 15,030,000 | 2026-01-12 17:00:10 |
| AKTS | Akoustis Technologies, Inc. | Geiss Arthur | Directior | 2024-01-29 | Buy | 50,000 | 0.50 | 25,000 | 2024-01-31 18:40:10 |
| AKTS | Akoustis Technologies, Inc. | Aichele David | EVP of Business Development | 2024-01-29 | Buy | 80,000 | 0.50 | 40,000 | 2024-01-31 18:39:56 |
| AKTS | Akoustis Technologies, Inc. | Boller Kenneth | CFO | 2024-01-29 | Buy | 60,000 | 0.50 | 30,000 | 2024-01-31 18:39:47 |
| AKTS | Akoustis Technologies, Inc. | Boller Kenneth | CFO | 2024-01-29 | Buy | 60,000 | 0.50 | 30,000 | 2024-01-31 18:39:47 |
| AKTS | Akoustis Technologies, Inc. | Shealy Jeffrey B. | Chief Executive Officer | 2024-01-29 | Buy | 1,310,000 | 0.50 | 655,000 | 2024-01-31 18:39:31 |
| AKTS | Akoustis Technologies, Inc. | Aichele David | EVP of Business Development | 2023-12-18 | Sell | 1,500 | 0.72 | 1,083 | 2023-12-20 17:03:00 |
| AKTS | Akoustis Technologies, Inc. | Boller Kenneth | CFO | 2023-12-18 | Sell | 1,200 | 0.72 | 865 | 2023-12-20 17:02:49 |
| AKTS | Akoustis Technologies, Inc. | Aichele David | EVP of Business Development | 2023-11-21 | Sell | 2,600 | 0.59 | 1,535 | 2023-11-22 17:35:21 |
| AKTS | Akoustis Technologies, Inc. | Boller Kenneth | CFO | 2023-11-21 | Sell | 1,700 | 0.59 | 1,001 | 2023-11-22 17:35:11 |
| AKTS | Akoustis Technologies, Inc. | Boller Kenneth | CFO | 2023-09-11 | Sell | 3,900 | 1.10 | 4,290 | 2023-09-13 17:26:52 |
| AKTS | Akoustis Technologies, Inc. | Aichele David | EVP of Business Development | 2023-09-11 | Sell | 5,300 | 1.09 | 5,777 | 2023-09-13 17:26:33 |
| AKTS | Akoustis Technologies, Inc. | Denbaars Steven | Directior | 2023-08-18 | Sell | 7,000 | 1.83 | 12,810 | 2023-08-22 19:11:59 |
| AKTS | Akoustis Technologies, Inc. | Boller Kenneth | CFO | 2023-02-10 | Sell | 800 | 4.37 | 3,496 | 2023-02-14 17:03:57 |
| AKTS | Akoustis Technologies, Inc. | Aichele David | EVP of Business Development | 2022-12-19 | Sell | 1,480 | 3.14 | 4,647 | 2022-12-21 17:04:03 |
| AKTS | Akoustis Technologies, Inc. | Boller Kenneth | CFO | 2022-12-19 | Sell | 1,200 | 2.92 | 3,504 | 2022-12-21 17:03:56 |
| AKTS | Akoustis Technologies, Inc. | Shealy Jeffrey B. | Chief Executive Officer | 2022-12-20 | Sell | 2,340 | 2.84 | 6,646 | 2022-12-21 17:03:10 |
| AKTS | Akoustis Technologies, Inc. | Denbaars Steven | Directior | 2022-12-06 | Sell | 7,000 | 3.57 | 24,990 | 2022-12-08 17:42:59 |
